House Panel OKs FDA User Fees Bill Despite Sticking Points

Law360, New York (May 8, 2012, 3:39 PM EDT) -- A key House subcommittee on Tuesday easily approved a bill to reauthorize the U.S. Food and Drug Administration's user fee programs, but leaders said the two sides still had issues to hammer out before the full committee takes up the bill Thursday.

In a voice vote during a brief hearing, the House Energy and Commerce Committee's health panel approved the package that was released Friday, which includes a host of FDA reforms, with only technical changes.

The committee, which has been working on the bill for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.